StockWatch
·
Biotechnology: Pharmaceutical Preparations
ShareholdingJun 15, 2026, 12:16 PM

Genmab: Orbis Investment Management Stake Drops to 4.99%

AI Summary

Genmab A/S announced that Orbis Investment Management Limited's stake in the company has decreased, falling below the 5% major shareholder threshold. As of June 12, 2026, Orbis Investment Management Limited controls 3,112,476 shares, representing 4.99% of Genmab's share capital and voting rights, down from a previous holding of 5.0783%. This change was reported under the Danish Capital Markets Act.

Key Highlights

  • Orbis Investment Management Limited's stake in Genmab A/S decreased to 4.99%.
  • This represents 3,112,476 shares and voting rights in Genmab A/S.
  • The previous reported holding by Orbis was 5.0783%.
  • The 5% major shareholder threshold was crossed on June 12, 2026.
  • Genmab A/S has a total of 62,353,067 voting rights.